TAF7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.640400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.660000E-01
Normal-vs-Stage2
5.624000E-01
Normal-vs-Stage3
3.494000E-01
Normal-vs-Stage4
6.902000E-01
Stage1-vs-Stage2
2.452200E-01
Stage1-vs-Stage3
1.703150E-01
Stage1-vs-Stage4
7.517000E-01
Stage2-vs-Stage3
3.219800E-01
Stage2-vs-Stage4
1.595420E-01
Stage3-vs-Stage4
1.122400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.777400E-01
Normal-vs-AfricanAmerican
3.099800E-01
Normal-vs-Asian
8.115800E-01
Caucasian-vs-AfricanAmerican
2.751200E-01
Caucasian-vs-Asian
9.232800E-01
AfricanAmerican-vs-Asian
4.301800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.951800E-01
Normal-vs-Female
6.408000E-01
Male-vs-Female
8.386600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.440000E-01
Normal-vs-Age(41-60Yrs)
8.622600E-01
Normal-vs-Age(61-80Yrs)
4.139600E-01
Normal-vs-Age(81-100Yrs)
5.161000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.638200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.303810E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.112800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.634400E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.456800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.638800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.339800E-01
Normal-vs-Daily Drinker
6.907400E-01
Normal-vs-Weekly Drinker
2.481000E-01
Normal-vs-Occasional Drinker
8.141600E-01
Normal-vs-Social Drinker
8.736400E-01
Non Drinker-vs-Daily Drinker
9.964200E-01
Non Drinker-vs-Weekly Drinker
2.154600E-01
Non Drinker-vs-Occasional Drinker
1.360160E-01
Non Drinker-vs-Social Drinker
5.945200E-01
Daily Drinker-vs-Weekly Drinker
2.985800E-01
Daily Drinker-vs-Occasional Drinker
2.062000E-01
Daily Drinker-vs-Social Drinker
6.498800E-01
Weekly Drinker-vs-Occasional Drinker
9.940000E-03
Weekly Drinker-vs-Social Drinker
1.396630E-01
Occasional Drinker-vs-Social Drinker
4.739000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.698300E-02
Normal-vs-Grade 2
1.261550E-03
Normal-vs-Grade 3
2.562000E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.410000E-01
Grade 1-vs-Grade 3
9.232200E-01
Grade 1-vs-Grade 4
9.698300E-02
Grade 2-vs-Grade 3
8.357800E-01
Grade 2-vs-Grade 4
1.261550E-03
Grade 3-vs-Grade 4
2.562000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.065800E-01
Normal-vs-NonDiabetic
8.110400E-01
Diabetic-vs-NonDiabetic
1.115840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.922000E-01
Normal-vs-NoPancreatitis
6.846800E-01
Pancreatitis-vs-NoPancreatitis
9.999400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.032600E-01
Normal-vs-N1
5.662600E-01
N0-vs-N1
2.721000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.264000E-01
Normal-vs-TP53-NonMutant
8.658400E-01
TP53-Mutant-vs-TP53-NonMutant
1.925420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
